72
KHADILKAR, V. V.; KHADILKAR, A. V.; MASKATI, G. B. Impact of availability of oral hydrocortisone
on growth of children with CAH. Indian J Pediatr, v.72, n.4, p.301-303, 2005.
KIRKLAND, R. T. et al. The effect of therapy on mature height in congenital adrenal hyperplasia.
J Clin Endocrinol Metab, v.47, p.1320-1324, 1978.
KLINGENSMITH, G. J. et al. Glucocorticoid treatment of girls with congenital adrenal hyperplasia:
effects on height, sexual maturation and fertility. J Pediatr, v.90, p.996-1004, 1977.
KORTH-SCHUTZ, S. et al. Serum androgens as a continuing index of adequacy of treatment
of congenital adrenal hyperplasia. J Clin Endocrinol Metab, v.46, n.3, p.452-458, 1978.
LARON, Z.; KAULI, R. Experience with cyproterone acetate in the treatment of precocious
puberty. J Pediatr Endocrinol Metab, v.13, Suppl. 1, p.805-810, 2000.
LEDER, B. Z. et al. Differential effects of androgens and estrogens on bone turnover in normal
men. J Clin Endocrinol Metab, v.88, n.1, p.204-210, 2003.
LEE, P. A. et al. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone
in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as
indicators of adrenal suppression. Horm Res, v.13, p.347-357, 1980.
LEMOS-MARINI, S. H. et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency:
final height in 27 patients with the classical form. Arq Bras Endocrinol Metabol, v.49, n.6,
p.902-907, 2005.
LIM, Y. J.; BATCH, J. A.; WARNE, G. L. Adrenal 21-hydroxylase deficiency in childhood: 25
years' experience. J Paediatr Child Health, v.31, p.222-227, 1995.
LINDER, B.; FEUILLAN, P.; CHROUSOS, G. P. Alternate day prednisone therapy in
congenital adrenal hyperplasia: adrenal androgen suppression and normal growth. J Clin
Endocrinol Metab, v.69, n.1, p.191-195, 1989.
LINDER, B. L.
Cortisol production rate in childhood and adolescence.
J Pediatr
, v.117, n.6, p.892-896,
1990.
LIN-SU, K. et al. Treatment with growth hormone and luteinizing hormone releasing hormone
analog improves final adult height in children with congenital adrenal hyperplasia. J Clin
Endocrinol Metab, v.90, n.6, p.3318-3325, 2005.
MAGIAKOU, M. A. Growth in disorders of adrenal hyperfunction. Pediatr Endocrinol Rev,
v.1, Suppl. 3, p.484-499, 2004.
MANOLI, I. et al. Early growth, pubertal development, body mass index and final height of
patients with congenital adrenal hyperplasia: factors influencing the outcome. Clin Endocrinol
(Oxf), v.57, n.5, p.669-676, 2002.
MATHEW, J.; SUDEEP, K. Is hydrocortisone really better? Indian J Pediatr, v.73, n.1,
p.107-108, 2006.
MERKE, D. P. et al. Adrenomedullary dysplasia and hypofunction in patients with classic 21-
hydroxilase deficiency. N Engl J Med, v.343, p.1362-1368, 2000(a).